Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Science

GlaxoSmithKline Provides an Update on the 3-Stage Validation Approach for Lyophilized Products at Lyophilisation 2014


Print article Print article
2014-04-17 12:55:08 - GlaxoSmithKline Provides an Update on the 3-Stage Validation Approach for Lyophilized Products at Lyophilisation 2014

With the ever increasing cost of pharmaceutical products, the importance of research into the formulation and stability of drugs has never been higher. World renowned companies from all over the globe use research to optimise the synthesis and storage of their products through the process of lyophilisation. Biological products ranging from proteins, vaccines to other injectables must remain effective from manufacture to patient administration.

GlaxoSmithKline will be speaking at this years' Lyophilisation conference to provide a case study and present the latest advances in the pharmaceutical and biopharmaceutical freeze-drying field.
Highlights from the presentation entitled: 3-stage validation approach for Lyophilized products, will include:
• Technology Transfer: Evaluation of an existing commercial product
• Development: Establishing a new lyophilised product
• Advancement: Discussion of

the latest methods in the freeze-drying field

Lyophilisation 2014 will provide a mix of case study led presentations, panel debates and keynote addresses that have been tailored to an audience of professionals involved in PAT implementation, mathematical modelling, design and scale-up, to optimising and validating freeze drying life cycles. The above is just a snap shot of what will be covered at the event. To download a brochure visit www.lyophilisation-conference.com.
Some of the confirmed attendees so far include: Boehringer Ingelheim, Allembis, Explicat Pharma, MedImmune, Novo Nordisk, GlaxoSmithKline, Norgine, Genzyme, Alexion Pharmaceuticals, Ellab, Ipsen, Ghent University, GEA Pharma Systems, GEA Process Engineering, Bavarian Nordic, Imperial College London plus many more.

For more information and full programme details, please visit:
Lyophilisation 2014: Pharmaceuticals & Biopharmaceuticals
7-8 July, 2014
Marriott Regents Park Hotel, London, UK
www.lyophilisation-conference.com

For those who are interested there is currently a £100 Early Bird discount ending 30 April available online.

About SMi Group
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries.
We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. We hold events in over 30 major cities throughout the world including London, Paris and Singapore and to date have welcomed over 200,000 participants from 80 countries.

For more information on this conference visit www.smi-online.co.uk or alternatively contact John Collins on +44(0) 207 827 6734 or email jcollins@smi-online.co.uk


Contact Information:
SMi Group Ltd

SMi Group Ltd
2nd Floor South, Harling House
47-51 Great Suffolk Street
London
SE1 0BS
United Kingdom

Contact Person:
John Collins
Sales Executive
Phone: +44(0) 207 827 6734
email: email

Web: www.lyophilisation-conference.com



Author:
Daniel Lee
e-mail
Web: www.smi-online.co.uk/
Phone: 02078276078

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com